Article ID Journal Published Year Pages File Type
8452856 Hematology/Oncology and Stem Cell Therapy 2018 5 Pages PDF
Abstract
Low fixed dose defibrotide initiated early seems to be effective and safe in treatment of VOD. This is relevant in a resource limited setting and warrants prospective evaluation.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Low, fixed dose defibrotide in management of hepatic veno-occlusive disease post stem cell transplantation
Authors
, , , ,